Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2022-03-02
Product name
DYAZIDE CAPSULES
Product Synonyms
DYAZIDE CAPSULES 25 MG/37.5 MG * TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FORMULATED PRODUCT
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H335, H413
Hazard statements
Code
Statements
H335
May cause respiratory irritation
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Specific target organ toxicity - single Category 3 respiratory tract irritation H335 - May cause respiratory exposure irritation.
Environmental hazards
Hazardous to the aquatic environment, Category 4 H413 - May cause long lasting long-term aquatic hazard harmful effects to aquatic life. Hazard summary May cause irritation to the respiratory system. Prolonged exposure may cause chronic effects. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards. Dangerous for the environment if discharged into watercourses.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
GLYCINE, HYDROCHLOROTHIAZIDE, TRIAMTERENE
Signal word
Warning
Hazard statements
H335 May cause respiratory irritation. H413 May cause long lasting harmful effects to aquatic life.
Prevention
P261 Avoid breathing dust. P261 Avoid breathing vapours. P271 Use only outdoors or in a well-ventilated area. P273 Avoid release to the environment.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P312 Call a POISON CENTRE/doctor/ if you feel unwell.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
7 % of the mixture consists of component(s) of unknown acute oral toxicity. 99 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 99 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 98 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
